Solar capital is an externally managed investment company that provides investors with access to an illiquid private credit asset class.
Business Model:
Revenue: $159.1M
Employees: 2-10
Address:
City:
State:
Zip:
Country:
Solar Capital is a closed-end, externally managed investment company that has elected to be treated as a business development company under the Investment Company Act of 1940 and intends to be taxed as a regulated investment company under Subchapter M of the Internal Revenue Code.
Contact Phone:
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
2/19/2010
Ticker Symbol:
SLRC
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
1/2015 | Trevi Therapeutics | Debt Financing | 15M |
9/2019 | scPharmaceuticals | Post-IPO Debt | 20M |
11/2016 | aTyr Pharma | Post-IPO Debt | 20M |
3/2018 | Corindus | Post-IPO Debt | 23M |
12/2020 | Neuronetics | Post-IPO Debt | 15M |
12/2020 | Neuronetics | Post-IPO Debt | 0 |
9/2019 | scPharmaceuticals | Post-IPO Debt | 0 |
3/2018 | Corindus | Post-IPO Debt | 0 |
11/2016 | aTyr Pharma | Post-IPO Debt | 0 |
1/2015 | Trevi Therapeutics | Debt Financing | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|